Cowen And Company, LLC Neurocrine Biosciences Inc Put Options Transaction History

Cowen And Company, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 13, 2021	SELL	$89.43 - $102.27 $581,295 - $664,755	-6,500 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$87.57 - $119.4 $525,420 - $716,400	-6,000 Reduced 48.0%	6,500 $77,000
Q4 2020 Feb 08, 2021	BUY	$86.91 - $108.33 $1.09 Million - $1.35 Million	12,500 New	12,500 $42,000

656

96.6M

282K

281K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.